In Brief: Acetaminophen Warnings, OTC HSA Bill, Durbin’s Supplement Reg Bill
This article was originally published in The Tan Sheet
Executive Summary
FDA adds acetaminophen warnings; CHPA suggests 4-aminophenol standard; OTC HSA bill in House; supplement registration bill reintroduced; FSMA user fees still on hold; more scrutiny of energy drinks; and Public Citizen pans OTC Oxytrol.
You may also be interested in...
Hearing Targets OTC Eligibility For Health Savings Funds
Louisiana Republican Rep. Charles Boustany Jr. says physician groups suggest the OTC prescription requirement imposes an unreasonable administrative burden, causes longer waits for appointments and increases health care costs.
Food Safety User Fees On Hold Until FDA Creates Waiver Process
Dietary supplement and food product firms will not incur user fees for facility or import re-inspections or mandatory recalls until FDA establishes a waiver process for small businesses.
CHPA Offers OTC Testing, Degradant Standards For Monograph Modernization
The Consumer Healthcare Products Association looks to shape U.S. Pharmacopeia's revision of monographs for OTC drug ingredients and products with proposals for the standard-setting organization's monograph modernization process.